Tamir Biotechnology, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1981-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://tamirbio.com
Safety and Efficacy Study of Topical Ranpirnase to Treat Genital Warts (HPV)
Phase 1
Completed
- Conditions
- Condylomata AcuminataPapillomavirus InfectionsSexually Transmitted Diseases
- Interventions
- Drug: Vehicle
- First Posted Date
- 2015-08-28
- Last Posted Date
- 2018-06-06
- Lead Sponsor
- Tamir Biotechnology, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT02535104
- Locations
- 🇧🇴
IDH, Cochabamba, Bolivia
A Study Of Ranpirnase(Onconase®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer
- First Posted Date
- 2010-08-18
- Last Posted Date
- 2015-09-02
- Lead Sponsor
- Tamir Biotechnology, Inc.
- Registration Number
- NCT01184287
- Locations
- 🇺🇸
Tower Cancer Research Foundation, Beverly Hills, California, United States
🇺🇸Sletten Cancer Specialists, Great Falls, Montana, United States
🇺🇸Van Andel Research Institute, Grand Rapids, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath